Posted in | News | Biofuels | Transportation | Energy

A Major Step Forward in the Development of Technologies to Reduce CO2 Emissions

Foster Wheeler Ltd. announced today that its Finnish subsidiary Foster Wheeler Energia Oy, part of its Global Power Group, has been awarded a contract by NSE Biofuels Oy Ltd. for a circulating fluidized-bed (CFB) biomass gasifier to be located in Varkaus, Finland. NSE Biofuels Oy Ltd. is a joint venture owned 50/50 by Stora Enso Oyj and Neste Oil Corporation.

Foster Wheeler’s scope includes an oxygen/steam gasifier and gas treatment equipment. The plant utilizes Foster Wheeler’s fuel-flexible circulating fluidized-bed gasification technology to convert a wide spectrum of biomass into a clean syngas to be used in a gas to liquids (Fischer-Tropsch) process to produce feedstock for renewable diesel from biomass/wood residue-based gas. The gasification and syngas cleaning system is part of NSE’s new-generation renewable diesel demonstration plant at Stora Enso’s Varkaus Mill in Finland.

Foster Wheeler has received a full notice to proceed on this contract. The terms of the award were not disclosed, and the contract will be included in the company’s bookings for the second quarter of 2008. The plant is expected to start up in early 2009 and will be integrated into the energy infrastructure of the Stora Enso Varkaus Mill.

Foster Wheeler and the JV partners have also agreed in principle for further co-operation, aiming for delivery of a commercial-scale production plant to be located at one of Stora Enso’s mills.

“This project is a major step forward in the development of technologies to reduce CO2 emissions,” said Tomas Harju-Jeanty, president and chief executive officer of Foster Wheeler Energia Oy. “With our world-leading biomass gasifying technology, we are excited to be a key player in this project led by Stora Enso and Neste Oil which uses wood-based biomass for production of biofuels, thereby reducing the use of fossil fuels in transportation.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.